Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Silencing Cholera's Social Media

May 25, 2016 8:26 am | by PLOS | News | Comments

Understanding how this works has potential for therapeutic purposes.


New Valeant CEO Discusses Turnaround Plan at Investor Conference

May 25, 2016 8:24 am | by Ryan Bushey, Digital Editor | Articles | Comments

Joseph Papa shed light on the potential strategy for reducing the drug maker's debt load.


Combination Immunotherapy Set to Become Integral Element of Renal Cell Carcinoma Treatment

May 25, 2016 8:24 am | by Maxime Bourgognon, PharmD, Oncology and Hematology Analyst, GlobalData | Articles | Comments

Combination approaches have the potential to generate twice as many sales in the recurrent RCC market.


Breakthrough Could Help Sufferers of Deadly Lung Disease

May 24, 2016 1:00 pm | by University of Sheffield | News | Comments

For the first time scientists have identified a molecule that promotes the progression of the disease which affects 6,500 people in the UK.


Sanofi's Diabetes Drug Faces Scrutiny from FDA

May 24, 2016 10:03 am | by Ryan Bushey, Digital Editor | Articles | Comments

An early review conducted by The Food and Drug Administration (FDA) of Sanofi’s combination diabetes drug iGlarLixi is raising issues related to efficacy.


Janssen's Stelara Maintained Clinical Remission After Year Of Treatment

May 24, 2016 9:21 am | News | Comments

Janssen Phase 3 data presented for the first time at Digestive Disease Week 2016 showed that a significantly greater proportion of adult patients with moderate to severe Crohn's disease receiving Stelara (ustekinumab) subcutaneous (SC) maintenance therapy were in clinical remission at one year. 


CDK4/6 Inhibitor Abemaciclib Most Active Against Breast Cancer, NSCLC

May 24, 2016 8:43 am | by Stephanie Guzowski, Editor | News | Comments

New results from a Phase 1 clinical trial that tested Eli Lilly’s investigational CDK4/6 inhibitor indicates that abemaciclib is likely in line to become an FDA-approved CDK4/6 inhibitor.


Cutting-Edge Findings in Cannabis Research

May 24, 2016 8:42 am | by De Gruyter Open | News | Comments

The recent legalization of cannabis for medical purposes in some US states has reinvigorated the debate over cannabis in Germany. 


Breast Cancer Drug Discovery Offers Hope for New Treatments

May 24, 2016 8:41 am | by University of Edinburgh | News | Comments

A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.


Yellow Fever Epidemic Threatens Spread from Angola to China

May 24, 2016 8:39 am | by Elsevier Health Sciences | News | Comments

The spread of yellow fever is a global health threat.


Catching Metastatic Cancer Cells Before They Grow Into Tumors

May 24, 2016 8:38 am | by Rachel M. Dudek and Lonnie Shea, University of Michigan, The Conversation | News | Comments

“Cure” is a word that’s dominated the rhetoric in the war on cancer for decades.


GSK Announces Impressive New Data for COPD Drug

May 24, 2016 8:38 am | News | Comments

Analyses remain ongoing and will be the subject of future publications and presentations.


Astellas, Daiichi Sankyo, and Takeda Announce R&D Collaboration on Biomarker Database

May 23, 2016 2:57 pm | News | Comments

All three firms aim to contribute to the enhancement of health and welfare of people around the world through creating innovative medicine.


Harvard Licenses Genotyping Platform

May 23, 2016 2:00 pm | by Harvard Gazette | News | Comments

The technology addresses the profound challenge of drug resistance among HIV-infected patients in resource-poor areas.


One Step Closer to Curing Diabetes

May 23, 2016 1:00 pm | by University of Technology, Sydney | News | Comments

The group is now working with US clinical stage biotechnology company PharmaCyte Biotech to commercialize the research.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.